Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Saved in:
Bibliographic Details
Title: Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Authors: Sherry L; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. L.W.Sherry@leeds.ac.uk., Grehan K; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Bahar MW; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Swanson JJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Fox H; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Matthews S; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Carlyle S; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Qin L; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Porta C; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Wilkinson S; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Robb S; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Clark N; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Liddell J; CPI, 1 Union Square, Central Park, Darlington, DL1 1GL, UK., Fry EE; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK., Stuart DI; Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford, OX3 7BN, UK.; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, OX3 7BN, UK., Macadam AJ; Division of Vaccines, Medicines & Healthcare products Regulatory Agency (MHRA), Herts, EN6 3QG, UK., Rowlands DJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. D.J.Rowlands@leeds.ac.uk., Stonehouse NJ; Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. N.J.Stonehouse@leeds.ac.uk.
Source: NPJ vaccines [NPJ Vaccines] 2026 May 29; Vol. 11 (1). Date of Electronic Publication: 2026 May 29.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-026-01470-4